ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency
August 04, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - August 04, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
July 20, 2016 09:00 ET
|
XOMA Corporation
XOMA 358 previously secured Orphan Drug Designation from the FDA for the treatment of Congenital Hyperinsulinism (CHI)Phase 2 clinical studies currently enrolling patients with CHI in the United...
Carbon Black is 'the Clear Leader' in Next-Gen Endpoint Security Says New EMA Report
March 16, 2016 08:26 ET
|
Carbon Black
WALTHAM, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- Carbon Black®, the leader in Next-Generation Endpoint Security (NGES), announced today that a new report from Enterprise Management Associates...
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now Securing Europe for Pancreatic Cancer Treatment
October 09, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - October 09, 2015) - The combination of PharmaCyte Biotech’s (OTCQB: PMCB) signature live-cell encapsulation technology, Cell-in-a-Box® with low doses of ifosfamide has...
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Ampligen/Rintatolimod for Ebola Virus Disease (EVD)
May 26, 2015 12:46 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European Medicines Agency (EMA) has published on May 22,...
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
May 11, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A.,...
Mesoblast Phase 3 Program For Degenerative Disc Disease To Include European Sites After Positive Meeting With European Medicines Agency
April 07, 2015 20:25 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, April 7, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that following positive feedback from its recent meeting with the...
Plixer and EMA Quantify Network Traffic Monitoring ROI
March 05, 2013 07:20 ET
|
Plixer International
KENNEBUNK, ME--(Marketwire - Mar 5, 2013) - As a leading provider of flow-based network traffic monitoring and threat detection technology, Plixer International, Inc., today announced a...
Innotas Hosts Free Webinar on "The Dawn of Integrated IT Management"
May 31, 2012 11:26 ET
|
Innotas
SAN FRANCISCO, CA--(Marketwire - May 31, 2012) - Innotas today announced a free webinar on "The Dawn of Integrated IT Management" featuring Charles Betz, Research Director of Enterprise Management...
CyberShift Expert to Present Session on Automating Employee Business Expenses at Upcoming Canadian Payroll Association Conference
May 26, 2009 10:00 ET
|
CyberShift
PARSIPPANY, NJ--(Marketwire - May 26, 2009) -
WHO:
Craig Fearon, senior product director, CyberShift, a leading global provider
of workforce management and expense management software and...